Stefan Rose-John researcher
Rose-John, Stefan 1954-
Rose-John, Stefan
VIAF ID: 120209694 (Personal)
Permalink: http://viaf.org/viaf/120209694
Preferred Forms
-
-
- 100 1 _ ‡a Rose-John, Stefan ‡d 1954-
- 100 1 _ ‡a Rose-John, Stefan ‡d 1954-
- 100 0 _ ‡a Stefan Rose-John ‡c researcher
4xx's: Alternate Name Forms (7)
5xx's: Related Names (4)
- 510 2 _ ‡a Biochemisches Institut Kiel
- 510 2 _ ‡a Christian-Albrechts-Universität zu Kiel ‡b Biochemisches Institut ‡4 affi ‡4 https://d-nb.info/standards/elementset/gnd#affiliation ‡e Affiliation
- 510 2 _ ‡a Heidelberg, Univ
- 551 _ _ ‡a Kiel ‡4 ortw ‡4 https://d-nb.info/standards/elementset/gnd#placeOfActivity
Works
Title | Sources |
---|---|
IL-6-induced FOXO1 activity determines the dynamics of metabolism in CD8 T cells cross-primed by liver sinusoidal endothelial cells | |
Activation of liver X receptors inhibits experimental fibrosis by interfering with interleukin-6 release from macrophages | |
Aufnahme und Transport von [Indol-Essigsäure] in Protonemen von Funaria hygrometrica | |
Case Report : Arterial Wall Inflammation in Atherosclerotic Cardiovascular Disease is Reduced by Olamkicept (sgp130Fc). | |
Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro | |
Corrigendum : Cathepsin D Variants Associated With Neurodegenerative Diseases Show Dysregulated Functionality and Modified α-Synuclein Degradation Properties | |
Differences in Shedding of the Interleukin-11 Receptor by the Proteases ADAM9, ADAM10, ADAM17, Meprin α, Meprin β and MT1-MMP | |
Differing outcome of experimental autoimmune encephalitis in macrophage/neutrophil- and T cell-specific gp130-deficient mice | |
Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: purification via inverse transition cycling | |
Funktionale Charakterisierung der Metalloprotease ADAM17 und ihrer natürlich vorkommenden Varianten | |
Funktionsanalyse der RNase H2 anhand muriner, konditionaler Knock-out Modelle | |
G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation | |
Genetically modified tumour vaccines (GMTV) in melanoma clinical trials | |
gp130 activation is regulated by D2-D3 interdomain connectivity. | |
gp130 dimerization in the absence of ligand: preformed cytokine receptor complexes | |
Gp130-Signaling synergizes with FL and TPO for the long-term expansion of cord blood progenitors | |
gp130-stimulating designer cytokine Hyper-interleukin-6 synergizes with murine stroma for long-term survival of primitive human hematopoietic progenitor cells. | |
GP130 stimulation and the maintenance of stem cells | |
Hepatocytes contribute to immune regulation in the liver by activation of the Notch signaling pathway in T cells. | |
Hitting a complex target: an update on interleukin-6 trans-signalling | |
Human herpesvirus 8-derived viral IL-6 induces PTX3 expression in Kaposi's sarcoma cells | |
Human interleukin-6 facilitates hepatitis B virus infection in vitro and in vivo. | |
Identification of a region within the cytoplasmic domain of the interleukin-6 (IL-6) signal transducer gp130 important for ligand-induced endocytosis of the IL-6 receptor | |
Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia | |
Identification of Single Amino Acid Residues of Human IL-6 Involved in Receptor Binding and Signal Initiation | |
AN IL-6/IL-6 SOLUBLE RECEPTOR (IL-6R) HYBRID PROTEIN (H-IL-6) INDUCES EPO-INDEPENDENT ERYTHROID DIFFERENTIATION IN HUMAN CD34+CELLS | |
IL6 Trans-signaling Promotes KRAS-Driven Lung Carcinogenesis. | |
Immunogene therapy of human melanoma. Phase I/II clinical trial. | |
Impact of interleukin-6 classic- and trans-signaling on liver damage and regeneration | |
Impaired hippocampus-dependent and -independent learning in IL-6 deficient mice. | |
Importance of soluble cytokine receptors for inflammation associated cancer | |
In vitro reconstitution of recognition and activation complexes between interleukin-6 and gp130. | |
In vivo evidence suggesting reciprocal renal hypoxia-inducible factor-1 upregulation and signal transducer and activator of transcription 3 activation in response to hypoxic and non-hypoxic stimuli | |
Inactivation of IL-6 and soluble IL-6 receptor by neutrophil derived serine proteases in cystic fibrosis | |
Increased inflammation and impaired resistance to Chlamydophila pneumoniae infection in Dusp1(-/-) mice: critical role of IL-6. | |
Increased inflammation and lethality of Dusp1-/- mice in polymicrobial peritonitis models. | |
Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection. | |
Inflammation-Induced IL-6 Functions as a Natural Brake on Macrophages and Limits GN. | |
Inhibition of IL-6 signaling significantly reduces primary tumor growth and recurrencies in orthotopic xenograft models of pancreatic cancer | |
Inhibition of protein kinase II (CK2) prevents induced signal transducer and activator of transcription (STAT) 1/3 and constitutive STAT3 activation. | |
Inhibition of T cell apoptosis in the aqueous humor of patients with uveitis by IL-6/soluble IL-6 receptor trans-signaling. | |
Initiation of Pancreatic Cancer : The Interplay of Hyperglycemia and Macrophages Promotes the Acquisition of Malignancy-Associated Properties in Pancreatic Ductal Epithelial Cells | |
Instructive Role of the Microenvironment in Preventing Renal Fibrosis | |
Interaction of vascular smooth muscle cells and monocytes by soluble factors synergistically enhances IL-6 and MCP-1 production | |
Interferon-gamma regulates alpha 2-macroglobulin and alpha 1-antichymotrypsin expression on the pretranslational level in HepG2 cells | |
Interleukin-11-driven gastric tumourigenesis is independent of trans-signalling. | |
Interleukin 17 drives vascular inflammation, endothelial dysfunction, and arterial hypertension in psoriasis-like skin disease | |
Interleukin 27 induces differentiation of neural C6-precursor cells into astrocytes. | |
Interleukin-31 and oncostatin-M mediate distinct signaling reactions and response patterns in lung epithelial cells | |
Interleukin-6: a villain in the drama of pancreatic cancer development and progression | |
Interleukin-6 and its receptors: a highly regulated and dynamic system | |
Interleukin-6 and neural stem cells: more than gliogenesis | |
Interleukin-6 and soluble interleukin-6 receptor: direct stimulation of gp130 and hematopoiesis | |
Interleukin-6 biology is coordinated by membrane bound and soluble receptors. | |
Interleukin 6-dependent genomic instability heralds accelerated carcinogenesis following liver regeneration on a background of chronic hepatitis | |
Interleukin-6: from basic biology to selective blockade of pro-inflammatory activities | |
Interleukin-6 (IL-6) and its soluble receptor support survival of sensory neurons | |
Interleukin-6 (IL-6) and soluble forms of IL-6 receptors are not altered in cerebrospinal fluid of Alzheimer's disease patients. | |
Interleukin-6 in sepsis and capillary leakage syndrome | |
Interleukin-6 receptor alpha blockade improves skin lesions in a murine model of systemic lupus erythematosus. | |
An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer | |
Interleukin-6 receptor-interleukin-6 fusion proteins with enhanced interleukin-6 type pleiotropic activities | |
Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells | |
Interleukin-6 trans-signaling in inflammatory bowel disease | |
Interleukin 6/Wnt interactions in rheumatoid arthritis : interleukin 6 inhibits Wnt signaling in synovial fibroblasts and osteoblasts | |
Natural Glycoforms of Human Interleukin 6 show atypical plasma clearance | |
A new multiple trauma model of the mouse | |
A New Type of Cytokine Receptor Antagonist Directly Targeting gp130 | |
A non-conservative polymorphism in the IL-6 signal transducer (IL6ST)/gp130 is associated with myocardial infarction in a hypertensive population | |
A Novel Small-Molecule Inhibitor Targeting the IL-6 Receptor β Subunit, Glycoprotein 130. | |
physiological relevance of ADAM17 in colon cancer development | |
physiologische Relevanz von ADAM17 in der Darmkarzinogenere | |
Recombinant human single chain Fv antibodies recognizing human interleukin-6. Specific targeting of cytokine-secreting cells. | |
Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction | |
Recombinant p35 from bacteria can form Interleukin (IL-)12, but Not IL-35 | |
Regulation of Interleukin-6 Receptor Cell-surface Levels by Internalization and Proteolysis | |
A role for the immunoglobulin-like domain of the human IL-6 receptor. Intracellular protein transport and shedding | |
role of the human RNase H2 for the mobilization of non-LTR-retrotransposons | |
role of the metalloprotease ADAM17 in metastasis | |
Roles for ADAM17 in TNF-R1 Mediated Cell Death and Survival in Human U937 and Jurkat Cells | |
A soluble form of the interleukin-6 family signal transducer gp130 is dimerized via a C-terminal disulfide bridge resulting from alternative mRNA splicing. | |
A switch from white to brown fat increases energy expenditure in cancer-associated cachexia. | |
synthetic retinoid acitretin increases IL-6 in the central nervous system of Alzheimer disease model mice and human patients | |
A variant in IL6ST with a selective IL-11 signaling defect in human and mouse |